Lophos Tablets 667Mg (10 Strip = 100 Tablets)

Targeted Management of Hyperphosphatemia

Lophos Tablets 667 mg are a prescription phosphate binder formulated with calcium acetate for the management of elevated serum phosphorus levels in patients with chronic kidney disease, particularly those with end-stage renal disease undergoing dialysis. Hyperphosphatemia is a common and serious complication in kidney disease, and effective control is essential to reduce long-term risks and maintain mineral balance.

How Lophos Tablets Work

When taken with meals, calcium acetate binds to dietary phosphate present in food. This binding forms an insoluble calcium phosphate complex that is not absorbed into the bloodstream and is instead eliminated through the feces. By reducing phosphate absorption from the gut, Lophos Tablets help lower serum phosphorus concentrations and support better biochemical control in patients with impaired kidney function.

First-Line Choice for CKD and ESRD Patients

Lophos Tablets are widely recognized as a first-choice therapy for treating hyperphosphatemia in patients with chronic kidney disease. Their targeted mechanism of action makes them particularly effective when used consistently with meals and in conjunction with a prescribed low-phosphate diet. This approach helps prevent complications such as bone and cardiovascular disorders associated with prolonged high phosphate levels.

Clinically Guided Dosing for Optimal Control

For adults on dialysis, treatment typically begins with two tablets taken with each meal. Based on individual response and laboratory values, the dose may be gradually increased to three or four tablets per meal to achieve and maintain serum phosphate levels below 6 mg/dL. Close medical supervision during dose adjustment is essential to avoid the development of hypercalcemia.

Safety Considerations and Monitoring

Because Lophos Tablets contain calcium, careful monitoring of serum calcium levels is required, especially early in treatment. Excessive calcium intake may lead to hypercalcemia, which can manifest as gastrointestinal discomfort, confusion, or more severe neurological symptoms in rare cases. Patients should strictly avoid additional calcium supplements, including non-prescription antacids, unless specifically directed by their healthcare provider.

Important Precautions and Interactions

Lophos Tablets should always be taken with meals to ensure effective phosphate binding. Certain medications, including tetracyclines and fluoroquinolone antibiotics, may interact with calcium acetate and should be taken at different times as advised by a physician. Patients should be informed about recognizing early symptoms of elevated calcium levels and the importance of adherence to dietary recommendations.

Storage and Responsible Use

Store Lophos Tablets at room temperature, away from direct light and heat, to maintain their effectiveness. Tablets should be swallowed whole and not crushed or chewed. As a prescription medicine, Lophos should only be used under the guidance of a qualified healthcare professional.

Take Control of Phosphate Balance Today

Managing phosphate levels is a critical part of kidney disease care. Lophos Tablets 667 mg provide a proven, targeted solution to help control hyperphosphatemia and support long-term kidney health.

Speak with your nephrologist or healthcare provider today to see if Lophos Tablets are the right choice for managing your phosphate levels effectively and safely.